Lupin zooms on turning black in Q2FY23

lupin surges on getting tentative usfda approval for mirabegron extended release tablets

Lupin is currently trading at Rs. 731.85, up by 37.80 points or 5.45% from its previous closing of Rs. 694.05 on the BSE. The scrip opened at Rs. 714.00 and has touched a high and low of Rs. 753.90 and Rs. 714.00 respectively. So far 154952 shares were traded on the counter. The BSE group … Read more

Lupin inches up as its arm signs definitive agreement to acquire two inhalation medicines

lupin surges on getting tentative usfda approval for mirabegron extended release tablets

Lupin is currently trading at Rs. 688.65, up by 0.55 points or 0.08% from its previous closing of Rs. 688.10 on the BSE. The scrip opened at Rs. 673.85 and has touched a high and low of Rs. 691.00 and Rs. 670.65 respectively. So far 81946 shares were traded on the counter. The BSE group … Read more

Lupin rises on getting USFDA’s approval for Rufinamide Tablets

lupin surges on getting tentative usfda approval for mirabegron extended release tablets

Lupin is currently trading at Rs. 688.15, up by 0.60 points or 0.09% from its previous closing of Rs. 687.55 on the BSE. The scrip opened at Rs. 685.00 and has touched a high and low of Rs. 691.80 and Rs. 678.85 respectively. So far 15453 shares were traded on the counter. The BSE group … Read more

Lupin rises on getting tentative approval for Ivacaftor Tablets from USFDA

lupin surges on getting tentative usfda approval for mirabegron extended release tablets

Lupin is currently trading at Rs. 612.10, up by 2.20 points or 0.36% from its previous closing of Rs. 609.90 on the BSE. The scrip opened at Rs. 607.00 and has touched a high and low of Rs. 614.60 and Rs. 603.00 respectively. So far 89358 shares were traded on the counter. The BSE group … Read more

Lupin moves up on the bourses

lupin surges on getting tentative usfda approval for mirabegron extended release tablets

Lupin is currently trading at Rs. 923.50, up by 20.05 points or 2.22% from its previous closing of Rs. 903.45 on the BSE. The scrip opened at Rs. 902.05 and has touched a high and low of Rs. 933.00 and Rs. 898.45 respectively. So far 150138 shares were traded on the counter. The BSE group … Read more

Lupin recalls generic oral contraceptive tablets in US

lupin surges on getting tentative usfda approval for mirabegron extended release tablets

Lupin is recalling 4,113 cartons of generic oral contraceptive tablets in the US, the world’s largest market for medicines, due to manufacturing issues. As per the latest enforcement report issued by the US Food and Drug Administration (USFDA), Lupin’s US-based unit is recalling 4,113 cartons of Tydemy (drospirenone, ethinyl estradiol & levomefolate calcium tablets, 3 … Read more

Lupin gains on launching Luforbec 100/6 dose

lupin surges on getting tentative usfda approval for mirabegron extended release tablets

Lupin is currently trading at Rs. 943.60, up by 4.05 points or 0.43% from its previous closing of Rs. 939.55 on the BSE. The scrip opened at Rs. 952.85 and has touched a high and low of Rs. 952.85 and Rs. 933.75 respectively. So far 40550 shares were traded on the counter. The BSE group … Read more

Lupin gains on launching Emtricitabine, Tenofovir Disoproxil Fumarate Tablets in US

lupin surges on getting tentative usfda approval for mirabegron extended release tablets

Lupin is currently trading at Rs. 1160.55, up by 8.20 points or 0.71% from its previous closing of Rs. 1152.35 on the BSE. The scrip opened at Rs. 1164.00 and has touched a high and low of Rs. 1164.00 and Rs. 1156.00 respectively. So far 4965 shares were traded on the counter. The BSE group … Read more